Type of security: Stock
Sector: Health Care
Industry: Industrial Specialties
Market Capitalization: 22.66 B
The data is delayed by 15 minutes.
Description: Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient?s diseased or defective heart valve; and produces pericardial valves from biologically inert animal tissue. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae that is used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patie
|Shares Outstanding||211.76 M||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||1.55%||Sales Growth - Q/Q||4.49%||P/E|
|P/E To EPS Growth||P/S||9.32||P/BV||9.9||Price/Cash Per Share||16.09|
|Price/Free Cash Flow||24.13||ROA||12.19%||ROE||19.22%||ROI||13.91%|
|Current Ratio||5.16||Quick Ratio||4.46||Long Term Debt/Equity||0.32||Debt Ratio||0.19|
|Gross Margin||74.38%||Operating Margin||23.69%||Net Profit Margin||18.08%||Dividend Payout Ratio|
|Cash From Financing Activities||-122.5 M||Cash From Investing Activities||-167.8 M||Cash From Operating Activities||243.4 M||Gross Profit||458.2 M|
|Net Profit||112.7 M||Operating Profit||142.2 M||Total Assets||3.61 B||Total Current Assets||2.3 B|
|Total Current Liabilities||445.2 M||Total Debt||600.3 M||Total Liabilities||1.32 B||Total Revenue||616.8 M|
|High 52 week||192.15||Low 52 week||127.36||Last close||174.33||Last change||-1.02%|
|RSI||28.21||Average true range||4.89||Beta||0.63||Volume||1.17 M|
|Simple moving average 20 days||-5.68%||Simple moving average 50 days||-3.82%||Simple moving average 200 days||9.22%|
|Performance Week||-2.21%||Performance Month||-7.64%||Performance Quart||3.56%||Performance Half||24.2%|
|Performance Year||34.5%||Performance Year-to-date||13.81%||Volatility daily||1.71%||Volatility weekly||3.81%|
|Volatility monthly||7.81%||Volatility yearly||27.07%||Relative Volume||162.97%||Average Volume||1.32 M|
|New High||New Low|
2019-06-14 16:29:35 | Why This Method Of Replacing A Faulty Heart Valve Is Gaining Steam
2019-06-13 09:36:04 | Read This Before Buying Edwards Lifesciences Corporation NYSE:EW Shares
2019-06-13 09:30:01 | HOLX or EW: Which Is the Better Value Stock Right Now?
2019-06-11 08:02:33 | See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
2019-06-10 08:04:46 | See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
2019-06-07 08:26:12 | DexCom and Companion Medical Collaboration to Support CGM
2019-05-29 11:38:56 | Why We Like Edwards Lifesciences Corporation’s NYSE:EW 23% Return On Capital Employed
2019-05-23 09:30:01 | Why Is Edwards Lifesciences EW Down 2.9% Since Last Earnings Report?
2019-05-22 02:30:00 | Edwards Announces Milestones For Transcatheter Mitral Program
2019-05-20 09:30:01 | HOLX vs. EW: Which Stock Is the Better Value Option?
2019-05-15 05:34:09 | Bull of the Day: Penumbra PEN
2019-05-10 07:52:07 | Investors Who Bought Edwards Lifesciences NYSE:EW Shares Five Years Ago Are Now Up 314%
2019-05-07 08:15:00 | Favorable Study Outcomes Presented On Edwards Aortic Valves With RESILIA Tissue
2019-05-07 08:03:13 | See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
2019-05-01 10:26:02 | Masimo Gets CE Mark for ANI Module, Enhances Root Platform
2019-05-01 10:05:00 | Edwards Lifesciences To Webcast Annual Meeting Of Stockholders
2019-04-26 17:47:53 | 5 Peter Lynch Stalwarts With Strong Operating Margins
2019-04-25 04:10:08 | Edwards Lifesciences EW Q1 Earnings Beat, EPS View Raised
2019-04-25 00:33:55 | Edited Transcript of EW earnings conference call or presentation 23-Apr-19 9:00pm GMT
2019-04-24 17:24:38 | Medtech Stock Skids On Its 'Off-Color Performance' Following FDA Jabs
2019-04-24 11:22:01 | Analysts Shrug Off Softness In Edwards Lifesciences' Heart Value Replacement System
2019-04-24 09:08:00 | EBay Stock Gains, Edwards Lifesciences Falls, and 3 More Wednesday Movers
2019-04-23 23:29:58 | Dow Jones Futures: Stock Market Rally At Tipping Point; 5 Big Earnings Movers
2019-04-23 23:14:50 | Edwards Lifesciences Corp EW Q1 2019 Earnings Call Transcript
2019-04-23 17:29:24 | This Medical Giant Beat Forecasts, But It's Losing Share In A Key Area
2019-04-23 16:39:29 | Edwards Lifesciences: 1Q Earnings Snapshot
2019-04-23 16:15:00 | Edwards Lifesciences Reports First Quarter Results
2019-04-23 11:35:52 | What You Must Know About Edwards Lifesciences Corporation's NYSE:EW Financial Health
2019-04-22 16:18:45 | Earnings From Twitter, Lockheed And These Top Stocks: Action Plan
2019-04-22 08:28:12 | Edwards Lifesciences Takes Over CAS Medical Systems for $100M
2019-04-19 09:15:01 | So Far, So Good for Earnings Season
2019-04-18 16:15:00 | Edwards Lifesciences Completes Acquisition of CASMED
2019-04-17 09:58:01 | What's in Store for Edwards Lifesciences' EW Q1 Earnings?
2019-04-16 10:31:02 | Edwards Lifesciences EW Earnings Expected to Grow: Should You Buy?
2019-04-15 17:54:28 | David Rolfe Comments on Edwards Lifesciences
2019-04-15 17:02:15 | David Rolfe's Wedgewood Partners 1st-Quarter 2019 Client Letter
2019-04-09 10:05:00 | Edwards Lifesciences To Host Earnings Conference Call On April 23, 2019
2019-04-05 09:17:00 | Why Edwards Lifesciences Gained 13% in March
2019-03-28 11:58:48 | Should You Avoid Edwards Lifesciences Corporation EW?
2019-03-28 10:42:02 | Can Retail Pharmacy USA Lift Walgreens' WBA Q2 Earnings?
2019-03-26 10:32:09 | Do Directors Own Edwards Lifesciences Corporation NYSE:EW Shares?
2019-03-22 10:52:02 | Should John Hancock Multifactor Mid Cap ETF JHMM Be on Your Investing Radar?